1.    Date the fine was imposed:September 15, 2025
2.    Recipient of the fine: Crystalvue Medical Corporation
3.    Legal basis of the fine: Paragraph 3 of Article 14 of the Securities and Exchange Act. 
4.    Facts of the violation and reasons: The financial statement for Q1 2025 presented upon regulatory filing by Crystalvue Medical Corporation was not signed or sealed by the accounting manager required under Article 3 of the Regulations Governing the Qualification Requirements and Professional Development of Principal Accounting Officers of Issuers, Securities Firms, and Securities Exchanges, pursuant to Paragraph 3 of Article 14 of the Securities and Exchange Act. Accordingly, it should be held violating said requirements.
5.    Resulting fine: Sentenced to the fine, NT$240,000, in accordance with Paragraph 1(2) of Article 178 and  179 of the Securities and Exchange Act.